Pseudocirrhosis caused by regorafenib in an advanced rectal cancer patient with multiple liver metastases.

about

Pseudocirrhosis caused by regorafenib in an advanced rectal cancer patient with multiple liver metastases.

Item

http://www.wikidata.org/entity/Q42329758

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Pseudocirrhosis caused by rego ...... ith multiple liver metastases.

@en

Pseudocirrhosis caused by rego ...... ith multiple liver metastases.

@nl

type

Item

label

Pseudocirrhosis caused by rego ...... ith multiple liver metastases.

@en

Pseudocirrhosis caused by rego ...... ith multiple liver metastases.

@nl

prefLabel

Pseudocirrhosis caused by rego ...... ith multiple liver metastases.

@en

Pseudocirrhosis caused by rego ...... ith multiple liver metastases.

@nl

P1476

Pseudocirrhosis caused by rego ...... with multiple liver metastases

@en

P2093

Azuma Nirei

http://www.w3.org/2001/XMLSchema#string

Daiki Nemoto

http://www.w3.org/2001/XMLSchema#string

Kazutomo Togashi

http://www.w3.org/2001/XMLSchema#string

Kensuke Kumamoto

http://www.w3.org/2001/XMLSchema#string

Noriyuki Isohata

http://www.w3.org/2001/XMLSchema#string

Shungo Endo

http://www.w3.org/2001/XMLSchema#string

Takuro Saito

http://www.w3.org/2001/XMLSchema#string

P2860

Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study

Sorafenib metabolism is significantly altered in the liver tumor tissue of hepatocellular carcinoma patient

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations

Regorafenib as a single-agent in the treatment of patients with gastrointestinal tumors: an overview for pharmacists.

Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: growth inhibition, quiescence, and recovery

Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer

Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancer

Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management.

Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules.

P304

63-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2016.1096

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kenichi Utano

P577

2016-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28123730

http://www.w3.org/2001/XMLSchema#string

P932

5244901

http://www.w3.org/2001/XMLSchema#string